CT and MRI features of Catenin Beta 1-mutated hepatocellular carcinoma in a Western cohort
Authors:
- 10 June 2025
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (1) , 50-62
Abstract
Objectives Various mutations in hepatocellular carcinoma (HCC) carry prognostic implications. The objective of this study is to assess CT and MRI imaging features associated with Catenin Beta-1 (CTNNB1) mutation in HCC. Methods This retrospective, IRB- approved multi-reader, single-center study included treatment-naive, pathologic-proven HCC that underwent contrast-enhanced CT, MRI or both, with subsequent targeted tumor sequencing test. Preoperative CT and MRI were reviewed for the Liver Imaging Reporting and Data System (LI-RADS, LR) features and prognostic imaging features. Fisher’s exact test and multiple testing adjustment were used to assess the association of imaging features and CTNNB1 mutation status. Results Of the 160 HCCs included (median age 69 [IQR: 62, 75], 125 men), 58 (36%) had CTNNB1 mutation. Compared to wildtype, CTNNB1-mutated HCCs were more likely to be present as solitary lesion (CT: 26/43[60%] vs. 31/80 [40%], p = 0.024), have mosaic appearance (MRI: 9/34[26%] vs. 3/68[4.4%], p = 0.002), blood products in mass (CT: 7/43[16%] vs. 2/80[2.5%], p = 0.009; MRI: 12/34[35%] vs. 8/68[12%], p = 0.008), necrosis (CT: 16/43[37%] vs. 14/80[18]%, p = 0.026), intralesional arteries (CT: 26/43[60%] vs. 32/80[40%], p = 0.038). A subgroup of 98 high risk patients (hepatitis B, morphologic cirrhosis) were assigned LI-RADS categorization; majority of patients were assigned LR-5 (CT: 15/25[60%] vs. 21/52[40%]; MRI: 10/18[56%] vs. 19/44[43%]). No feature was significantly associated with CTNNB1 mutation status after multiple testing adjustment. Conclusion Compared to wildtype, CTNNB1-mutated HCCs are more likely to appear as solitary masses with mosaic, heterogeneous appearance containing blood products, necrosis and intralesional arteries. Majority of CTNNB1-mutated tumors were categorized as LR-5 in a subgroup of high risk patients. No imaging feature independently predicted CTNNB1-mutated HCCs.Keywords
This publication has 23 references indexed in Scilit:
- Trends in Hepatocellular Carcinoma Mortality Rates in the US and Projections Through 2040JAMA Network Open, 2024
- Specific features of ß-catenin-mutated hepatocellular carcinomasBritish Journal of Cancer, 2024
- Diagnostic Model for Proliferative HCC Using LI‐RADS: Assessing Therapeutic Outcomes in Hepatectomy and TKI‐ICI CombinationJournal of Magnetic Resonance Imaging, 2024
- AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinomaHepatology, 2023
- Molecular and histological correlations in liver cancerJournal of Hepatology, 2019
- Mosaic architecture of hepatocellular carcinomaAbdominal Radiology, 2017
- LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasoundAbdominal Radiology, 2017
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortalScience Signaling, 2013
- The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imagingEuropean Radiology, 2011
- Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomasOncogene, 2002